News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
582,903 Results
Type
Article (25737)
Company Profile (203)
Press Release (556951)
Multimedia
Podcasts (50)
Webinars (21)
Section
Business (194808)
Career Advice (1055)
Deals (29129)
Drug Delivery (88)
Drug Development (61336)
Employer Resources (147)
FDA (11368)
Job Trends (11331)
News (277239)
Policy (21908)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (2)
2027 Genetown Standard (5)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (7)
Academia (1769)
Academic (2)
Accelerated approval (37)
ADA (27)
Adcomms (18)
Allergies (124)
Alliances (40793)
ALS (160)
Alzheimer's disease (1410)
Antibody-drug conjugate (ADC) (390)
Approvals (12020)
Artificial intelligence (608)
ASCO (219)
Autoimmune disease (285)
Automation (50)
Bankruptcy (292)
Best Places to Work (8732)
BIO (53)
Biologics (2)
BIOSECURE Act (12)
Biosimilars (176)
BioSpace Insights (124)
Biotechnology (122)
Bladder cancer (154)
Brain cancer (46)
Breast cancer (624)
Cancer (4695)
Cardiovascular disease (343)
Career advice (940)
Career pathing (48)
CAR-T (257)
CDC (26)
CDMO (53)
Celiac Disease (1)
Cell therapy (688)
Cervical cancer (46)
Clinical research (54380)
Collaboration (1839)
Commercialization (6)
Company closure (1)
Compensation (1524)
Complete response letters (46)
COVID-19 (1514)
CRISPR (100)
C-suite (1155)
Cystic fibrosis (124)
Data (6981)
Decentralized trials (2)
Denatured (32)
Depression (139)
Dermatology (83)
Diabetes (456)
Diagnostics (5460)
Digital health (52)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (317)
Drug pricing (61)
Drug shortages (8)
Duchenne muscular dystrophy (225)
Earnings (78321)
Editorial (25)
Employer branding (23)
Employer resources (127)
Events (101395)
Executive appointments (1013)
FDA (14609)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (26)
Funding (1530)
Gene editing (187)
Generative AI (46)
Gene therapy (477)
GLP-1 (607)
Government (2086)
Grass and pollen (2)
Guidances (342)
Healthcare (12132)
Hematology (122)
HIV (80)
Huntington's disease (44)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (83)
Immunology and inflammation (153)
Immuno-oncology (74)
Indications (187)
Infectious disease (1766)
Inflammatory bowel disease (177)
Inflation Reduction Act (10)
Influenza (104)
Intellectual property (296)
Interviews (155)
IPO (13724)
IRA (17)
Job creations (2836)
Job search strategy (804)
JPM (28)
Kidney cancer (19)
Labor market (108)
Layoffs (261)
Leadership (25)
Legal (5783)
Licensing (12)
Liver cancer (63)
Longevity (27)
Lung cancer (650)
Lymphoma (361)
Machine learning (48)
Management (45)
Manufacturing (839)
Marketing (9)
MASH (136)
Medical device (9915)
Medtech (10088)
Mergers & acquisitions (16616)
Metabolic disorders (1010)
mRNA (128)
Multiple sclerosis (164)
NASH (13)
Neurodegenerative disease (324)
Neuropsychiatric disorders (62)
Neuroscience (2634)
Neurotech (1)
NextGen: Class of 2026 (4387)
Non-profit (2252)
Now hiring (84)
Obesity (393)
Opinion (163)
Ovarian cancer (196)
Pain (203)
Pancreatic cancer (218)
Parkinson's disease (278)
Partnered (29)
Patents (545)
Patient recruitment (617)
Peanut (42)
People (52161)
Pharmaceutical (44)
Pharmacy benefit managers (11)
Phase 1 (17386)
Phase 2 (24071)
Phase 3 (17109)
Pipeline (8901)
Policy (140)
Postmarket research (1845)
Preclinical (7755)
Press Release (70)
Prostate cancer (239)
Psychedelics (35)
Radiopharmaceuticals (247)
Rare diseases (807)
Real estate (4551)
Recruiting (62)
Regulatory (18107)
Reports (63)
Research institute (1658)
Resumes & cover letters (143)
Rett syndrome (43)
RNA editing (13)
RSV (69)
Schizophrenia (143)
Series A (271)
Series B (191)
Service/supplier (8)
Sickle cell disease (93)
Special edition (15)
Spinal muscular atrophy (115)
Sponsored (24)
Startups (3138)
State (1)
Stomach cancer (8)
Supply chain (79)
Tariffs (17)
The Weekly (18)
Vaccines (603)
Venture capital (108)
Weight loss (190)
Women's health (111)
Worklife (21)
Date
Today (135)
Last 7 days (399)
Last 30 days (1950)
Last 365 days (23655)
2026 (15900)
2025 (23484)
2024 (27985)
2023 (32106)
2022 (40492)
2021 (43942)
2020 (40427)
2019 (31348)
2018 (23427)
2017 (23876)
2016 (23401)
2015 (29535)
2014 (25478)
2013 (21679)
2012 (23598)
2011 (24090)
2010 (23759)
Location
Africa (491)
Alabama (90)
Alaska (5)
Arizona (352)
Arkansas (12)
Asia (25599)
Australia (3855)
California (13205)
Canada (3552)
China (870)
Colorado (574)
Connecticut (486)
Delaware (351)
Europe (48200)
Florida (1968)
Georgia (437)
Hawaii (5)
Idaho (49)
Illinois (870)
India (88)
Indiana (552)
Iowa (26)
Japan (489)
Kansas (121)
Kentucky (39)
Louisiana (37)
Maine (35)
Maryland (1387)
Massachusetts (9204)
Michigan (361)
Minnesota (727)
Mississippi (7)
Missouri (108)
Montana (24)
Nebraska (17)
Nevada (135)
New Hampshire (70)
New Jersey (3174)
New Mexico (25)
New York (3362)
North Carolina (1582)
North Dakota (11)
Northern California (6663)
Ohio (352)
Oklahoma (19)
Oregon (33)
Pennsylvania (2492)
Puerto Rico (24)
Rhode Island (40)
South America (678)
South Carolina (82)
South Dakota (1)
Southern California (5378)
Tennessee (172)
Texas (2199)
United States (44990)
Utah (414)
Vermont (2)
Virginia (207)
Washington D.C. (64)
Washington State (1063)
West Virginia (2)
Wisconsin (142)
Wyoming (2)
582,903 Results for "tga sciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cambrex High Point Completes FDA, PMDA and TGA Pre-Approval Inspections, Advancing Commercial Manufacturing Capabilities
August 25, 2026
·
2 min read
Press Releases
4DMedical Receives TGA Approval for CT:VQ™, Bringing Non-Contrast Ventilation-Perfusion Imaging to Australia
June 29, 2026
·
4 min read
Press Releases
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO
April 29, 2026
·
5 min read
Press Releases
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS)
May 1, 2026
·
10 min read
Press Releases
Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
May 6, 2026
·
5 min read
Press Releases
OS Therapies Schedules OST-HER2 Pharmacodynamic Response Biomarker Conference Call on April 30, 2026 at 8:30am ET
• Regulatory feedback recent from April 2026 EU EMA and Australian TGA meetings • Remaining Q2-2026 regulatory meetings include two U.S. FDA meetings and one UK MHRA meeting, in addition to follow-up meetings with EU EMA and Australian TGA
April 27, 2026
·
5 min read
Press Releases
Noveris Health Sciences Inc. Unaware of Any Material Change
August 6, 2026
·
1 min read
Immunology and inflammation
AB Science ends 3 studies in multiple sclerosis, other immune conditions
The trials, which were testing the tyrosine kinase inhibitor masitinib, had previously been paused. AB Science’s decision not to resume them was a matter of prioritization, not safety, the biotech said.
July 13, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NurExone Biologic Inc. to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
August 30, 2026
·
6 min read
Press Releases
L7 Informatics Advocates for Neuro-Symbolic AI in Regulated Life Sciences
L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.
July 23, 2026
·
1 min read
1 of 58,291
Next
